Pharmaron Beijing Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Kanglong Huacheng (Beijing) New Drug Technology Co., Ltd. (stock code: 300759. SZ/3759. HK) is an internationally leading life science research and development service enterprise. Since its establishment in 2004, Kanglong Huacheng has been committed to talent cultivation and facility construction, creating a R&D and production service system that runs through the entire process of drug discovery, preclinical, and clinical development for the development of multi therapy drugs, including small molecule, large molecule, and cell and gene therapy drugs. Kanglong Huacheng operates in China, the United States, and the United Kingdom, with over 14000 employees, providing research and development solutions to partners in North America, Europe, Japan, and China, and maintaining good cooperative relationships with them. |
| Headquarter | Beijing |
| Establish Date | 7/1/2004 |
| Listed Code | 300759.SZ |
| Listed Date | 1/28/2019 |
| Chairman | Boliang Lou |
| CEO | Boliang Lou |
| Website | www.pharmaron.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
